Analyst RecommendationAnalyst reiterates Buy rating with a higher price objective of $38.00, reflecting confidence in the company's performance and future prospects.
Earnings PerformanceThe company reported EPS of $1.01, surpassing expectations due to a lower provision for losses and a significant reserve release.
Financial HealthSolid quarterly performance with a 17.4% year-over-year increase in book value, indicating strong underlying financial health.